SADA Y-PRIT
Live / Registered — Registered (as of 03 Jun 2025)
What this means for you
Registered since 03 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98033275
- Registration number
- 7813863
- Mark type
- Stylized text
- Filed
- 08 Jun 2023
- Published for opposition
- 15 Apr 2025
- Registered
- 03 Jun 2025
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies; Research and development services in the field of antibody technology; Laboratory research and analysis in the field of the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of oncology, chemotherapy, and inflammatory diseases; Industrial analysis and research services in the field of chemistry
Owner
- Y-mAbs Therapeutics, Inc, New York, NY, US
- Y-mAbs Therapeutics, Inc, New York, NY, US
- Y-mAbs Therapeutics, Inc, New York, NY, US
Prior registrations
Prosecution history
- 03 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jan 2025 — CASE RETURNED TO EXAMINATION
- 14 Nov 2024 — NOTICE OF ALLOWANCE CANCELLED
- 23 Dec 2024 — CASE RETURNED TO EXAMINATION
- 23 Dec 2024 — CASE RETURNED TO EXAMINATION
- 23 Dec 2024 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 23 Dec 2024 — REINSTATED
- 23 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Dec 2024 — TEAS RESPONSE TO PETITION INQUIRY LETTER
- 19 Dec 2024 — PETITION INQUIRY LETTER ISSUED